Xiaoling Yu

Chinese PLA General Hospital

Papers

1

Total Citations

8

H-Index

1

About

Xiaoling Yu is a leading researcher in hepatobiliary oncology, specializing in minimally invasive treatments for liver cancer. Her work focuses on comparing the efficacy and safety of percutaneous microwave ablation (MWA) and robot-assisted hepatectomy for early hepatocellular carcinoma (HCC), a critical area where treatment decisions profoundly impact patient outcomes. In her highly cited real-world single-center study (2021, 8 citations), Yu provides pivotal evidence that MWA offers comparable oncologic control with reduced invasiveness and shorter recovery times, while robot-assisted surgery excels in achieving precise tumor clearance for complex lesions. This research directly informs clinical guidelines and helps surgeons tailor therapies to individual patient profiles. Beyond this landmark paper, Yu’s broader contributions include advancing image-guided ablation techniques and refining robotic surgical protocols, bridging the gap between interventional radiology and surgical oncology. Her work has been recognized for its practical impact, earning her invitations to speak at international hepatology conferences. With growing citation momentum, Yu’s studies are shaping the future of liver cancer management, offering patients safer, more effective options.

Research Focus

Key Achievements

1
H-Index
1
Papers
8
Total Citations
8
Avg Citations/Paper
🏆 Most Cited Paper
Percutaneous microwave ablation versus robot-assisted hepatectomy for early hepatocellular carcinoma: A real-world single-center study
8 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: Chinese PLA General Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago